Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3 clinical trials
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

This study will assess the efficacy and safety of capivasertib plus abiraterone (+prednisone/prednisolone) plus androgen deprivation therapy (ADT) versus placebo plus abiraterone (+prednisone/prednisolone) plus ADT in participants with mHSPC whose tumours are characterised by PTEN deficiency.

bone metastases
prostate cancer
soft tissue lesion
adenocarcinoma
steroid therapy
  • 0 views
  • 16 Feb, 2024
  • 107 locations
Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer

This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.

abiraterone
androgens
bilateral orchidectomy
metastatic hormone refractory prostate cancer
prostate cancer
  • 0 views
  • 05 Aug, 2020
Test Trial 002  

test comment here

  • 0 views
  • 05 Apr, 2023
  • 1 location